BiondVax Pharmaceuticals Ltd.

BVXV · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$6-$40-$4-$109
Dep. & Amort.$1$2$2$2
Deferred Tax$0-$0-$0-$0
Stock-Based Comp.$2$9$9$4
Change in WC$0$5-$93$11
Other Non-Cash-$4-$1$13$16
Operating Cash Flow-$7-$24-$73-$77
Investing Activities
PP&E Inv.-$1-$0-$6-$7
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$0-$6-$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$69$0$70
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7$68$14$85
Financing Cash Flow$7$68$14$85
Forex Effect-$2$2$2-$4
Net Chg. in Cash-$3$45-$63-$3
Supplemental Information
Beg. Cash$18$9$72$76
End Cash$14$54$9$72
Free Cash Flow-$8-$25-$79-$84